Susquehanna International Group, LLP Supernus Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$25.77 - $35.16 $20,616 - $28,127	800 Added 10.13%	8,700 $271,000
Q2 2024 Aug 15, 2024	SELL	$25.99 - $33.85 $436,632 - $568,680	-16,800 Reduced 68.02%	7,900 $211,000
Q1 2024 May 07, 2024	BUY	$27.11 - $35.17 $452,737 - $587,339	16,700 Added 208.75%	24,700 $842,000
Q4 2023 Feb 14, 2024	BUY	$22.72 - $29.68 $181,760 - $237,440	8,000 New	8,000 $231,000
Q2 2023 Aug 11, 2023	BUY	$29.91 - $38.73 $269,190 - $348,570	9,000 New	9,000 $270,000
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $28,790 - $35,410	1,000 Added 11.24%	9,900 $335,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.